Allworth Financial’s iShares Biotechnology ETF IBB Stock Holding History

Allworth Financial’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$876K	Sell	4,604 -165	-3%	-$28.4K	﹤0.01%	766
2026 Q1	$805K	Buy	4,769 +265	+6%	+$45.3K	﹤0.01%	776
2025 Q4	$760K	Sell	4,504 -1,302	-22%	-$211K	﹤0.01%	778
2025 Q3	$838K	Sell	5,806 -256	-4%	-$34.9K	﹤0.01%	717
2025 Q2	$767K	Buy	6,062 +4,313	+247%	+$529K	﹤0.01%	711
2025 Q1	$217K	Sell	1,749 -344	-16%	-$46.6K	﹤0.01%	921
2024 Q4	$285K	Buy	2,093 +564	+37%	+$79.3K	﹤0.01%	838
2024 Q3	$223K	Hold	1,529	–	–	﹤0.01%	786
2024 Q2	$220K	Sell	1,529 -75	-5%	-$10K	﹤0.01%	785
2024 Q1	$220K	Sell	1,604 -13	-0.8%	-$1.77K	﹤0.01%	755
2023 Q4	$220K	Sell	1,617 -210	-11%	-$25.6K	﹤0.01%	706
2023 Q3	$223K	Sell	1,827 -137	-7%	-$17.4K	﹤0.01%	661
2023 Q2	$249K	Sell	1,964 -56	-3%	-$7.28K	﹤0.01%	644
2023 Q1	$261K	Sell	2,020 -427	-17%	-$55.9K	﹤0.01%	598
2022 Q4	$321K	Buy	2,447 +941	+62%	+$122K	﹤0.01%	542
2022 Q3	$176K	Sell	1,506 -4	-0.3%	-$497	﹤0.01%	614
2022 Q2	$178K	Sell	1,510 -124	-8%	-$14.7K	﹤0.01%	581
2022 Q1	$213K	Buy	1,634 +432	+36%	+$56.3K	﹤0.01%	540
2021 Q4	$183K	Hold	1,202	–	–	﹤0.01%	550
2021 Q3	$194K	Buy	1,202 +724	+151%	+$122K	﹤0.01%	491
2021 Q2	$78K	Buy	478 +50	+12%	+$7.7K	﹤0.01%	523
2021 Q1	$64K	Hold	428	–	–	﹤0.01%	522
2020 Q4	$65K	Buy	428 +38	+10%	+$5.43K	﹤0.01%	431
2020 Q3	$53K	Buy	390 +2	+0.5%	+$271	﹤0.01%	413
2020 Q2	$53K	Buy	388 +48	+14%	+$6.12K	﹤0.01%	409
2020 Q1	$37K	Hold	340	–	–	﹤0.01%	448
2019 Q4	$41K	Sell	340 -112	-25%	-$12.5K	﹤0.01%	400
2019 Q3	$45K	Hold	452	–	–	﹤0.01%	345
2019 Q2	$49K	Hold	452	–	–	﹤0.01%	321
2019 Q1	$51K	Hold	452	–	–	﹤0.01%	309
2018 Q4	$44K	Buy	452 +44	+11%	+$4.67K	﹤0.01%	299
2018 Q3	$50K	Hold	408	–	–	﹤0.01%	296
2018 Q2	$45K	Hold	408	–	–	﹤0.01%	300
2018 Q1	$44K	Hold	408	–	–	﹤0.01%	267
2017 Q4	$44K	Hold	408	–	–	﹤0.01%	266
2017 Q3	$45K	Hold	408	–	–	﹤0.01%	252
2017 Q2	$42K	Buy	408 +297	+268%	+$29.3K	﹤0.01%	271
2017 Q1	$11K	Hold	111	–	–	﹤0.01%	434
2016 Q4	$10K	Buy	+111	New	+$10.1K	﹤0.01%	403

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Allworth Financial's IBB Position: Q2 2026 in Review

Allworth Financial reduced its iShares Biotechnology ETF (IBB) stake by 3.5% in Q2 2026, selling an estimated $28.4K and leaving 4,604 shares worth $876K. The position accounts for ﹤0.01% of the portfolio, ranked #766.

Allworth Financial first reported a position in IBB in Q4 2016 and has held it in 39 quarters since. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Allworth Financial held 4,604 shares of iShares Biotechnology ETF worth $876K as of Q2 2026.
Allworth Financial sold 165 iShares Biotechnology ETF shares in Q2 2026, an estimated $28.4K.
iShares Biotechnology ETF made up ﹤0.01% of Allworth Financial's portfolio in Q2 2026, its #766 holding.
Allworth Financial first reported a position in iShares Biotechnology ETF in Q4 2016 and has held it in 39 quarters since.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Allworth Financial's 13F filing for Q2 2026, filed 11 Aug 2026.